Skip to main content
H

Huna

Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.

São Paulo, BrazilFounded 2021332K+ followers
Updated 4 months ago

Funding

$850K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Early cancer detection relies on specialized screening methods, which can be costly, invasive, and not always integrated into routine healthcare. This often leads to delayed diagnoses, reducing treatment effectiveness and increasing healthcare costs.

Solution

Huna has developed an AI-powered engine that analyzes data from routine blood tests to identify risk patterns associated with early-stage cancers and other chronic diseases. By applying machine learning algorithms to existing lab results, Huna provides healthcare providers with a risk classification for each patient, enabling earlier detection and intervention. The technology aims to improve clinical decision-making, increase the chances of successful treatment, and optimize healthcare resource allocation. Huna's solution integrates into existing clinical workflows, leveraging readily available data to provide actionable insights.

Target Audience

Huna's primary customers include healthcare providers, laboratories, and companies seeking to improve early disease detection and offer proactive health monitoring to patients and employees.

Features

  • AI-driven analysis of routine blood test data to identify potential cancer risks.
  • Risk classification of patients based on blood test patterns.
  • Integration with existing healthcare systems and clinical analysis processes.
  • Identification of risk patterns for multiple types of cancer and chronic diseases.
  • Support for early diagnosis and proactive patient management.
This profile is AI-generated and may contain inaccuracies.